Covista Inc.
No enriched coverage for $CVSA in the last 7 days.
Evercore initiates Lumentum (LITE) at Outperform with a $1,100 target, citing strong demand for Indium Phosphide lasers in AI. Jefferies upgrades Sempra Energy (SRE) to Buy, seeing undervaluation. TD Cowen downgrades Eyepoint (EYPT) to Hold, citing poor trial results. Truist downgrades Covista (CVSA) to Hold, citing valuation concerns. Baird upgrades Sonida Senior Living (SNDA) to Outperform, citing demographic trends.
A Q2 earnings “teardown” covers education services stocks. Lincoln Educational (CVSA) reported $142.6M revenue, up 22.4% YoY, beating EPS and EBITDA estimates; shares fell 26.5% to $30.12. Strategic Education (STRA) revenue rose 4.9% to $337.3M but missed EPS. Laureate (LAUR) revenue $615.9M, up 17.5%, beat; shares down 2.4% to $37.50. Bright Horizons (BFAM) revenue $779.2M, up 6.5%, beat; shares down 8.5% to $71.33.
BECK DOUGLAS G. (SVP, GC, Corp. Sec & ISS) sold 4,526 shares of Covista Inc. (CVSA) at $135.81 ($0.61M total) on 2026-08-07 under a Rule 10b5-1 trading plan.
Recent CVSA coverage spans earnings, insider activity and financial news.
In the last 30 days, CVSA insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($247K). The most active reporter was Gangadharan Manjunath, VP, Chief Accounting Officer, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Downgrade reflects skepticism about growth prospects.
Earnings beat did not translate into investor approval, implying the market is focused on something beyond the reported top-line and estimate beats.
This is a routine 10b5-1 open-market sale by a senior insider, with limited direct signal for near-term fundamentals.
The article frames the move as an earnings quality and guidance signal, not just a one-quarter beat, with operating margin expansion supporting a re-rating thesis.
The Q2 beat plus above-consensus full-year adjusted earnings guidance is a near-term re-rating catalyst for CVSA, with operating margin expansion supporting quality of earnings.
AlphAI scores every news story that mentions CVSA with an AI model for sentiment and relevance, and aggregates insider trades from Covista Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Evercore initiates Lumentum (LITE) at Outperform with a $1,100 target, citing strong demand for Indium Phosphide lasers in AI. Jefferies upgrades Sempra Energy (SRE) to Buy, seeing undervaluation. TD Cowen downgrades Eyepoint (EYPT) to Hold, citing poor trial results. Truist downgrades Covista (CVSA) to Hold, citing valuation concerns. Baird upgrades Sonida Senior Living (SNDA) to Outperform, citing demographic trends.
3 min readA Q2 earnings “teardown” covers education services stocks. Lincoln Educational (CVSA) reported $142.6M revenue, up 22.4% YoY, beating EPS and EBITDA estimates; shares fell 26.5% to $30.12. Strategic Education (STRA) revenue rose 4.9% to $337.3M but missed EPS. Laureate (LAUR) revenue $615.9M, up 17.5%, beat; shares down 2.4% to $37.50. Bright Horizons (BFAM) revenue $779.2M, up 6.5%, beat; shares down 8.5% to $71.33.
7 min readBECK DOUGLAS G. (SVP, GC, Corp. Sec & ISS) sold 4,526 shares of Covista Inc. (CVSA) at $135.81 ($0.61M total) on 2026-08-07 under a Rule 10b5-1 trading plan.
2 min readCovista (NYSE:CVSA) shares rose about 13% after the company reported Q2 2026 revenue of $501.4 million (+9.7% YoY) and adjusted EPS of $2.09, both above Wall Street estimates. The firm also expanded operating margin to 19% from 16.8% and issued full-year adjusted earnings guidance above consensus. Shares closed near $140.91.
4 min readCovista (NYSE: CVSA) shares rose about 13% after the company reported Q2 2026 revenue of $501.4 million, up 9.7% year over year, and adjusted EPS of $2.09, about 10% above Wall Street estimates. Operating margin increased to 19% from 16.8%. Covista also issued full-year adjusted earnings guidance above consensus; shares closed around $140.91.
4 min readCovista (NYSE:CVSA), formerly DeVry Education Group, reported Q2 CY2026 revenue of $501.4 million, up 9.7% year on year and 3.1% above Wall Street estimates, according to the company. It guided full-year revenue to about $2.07 billion. Non-GAAP EPS was $2.09, 10.4% above consensus, and analysts expect full-year EPS to rise from $8.25 to $8.75.
5 min readCovista Inc. (CVSA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Investor Contact: Jeremy Cohen Investor.Relations@Covista.com +1 312-906-6600 Media Contact: Maureen Bender CovistaMedia@Covista.com +1 313-319-4732 Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; Initiates Fiscal Year 2027 Guidance Total Q4
6 min readCovista Inc. (CVSA) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Covista Inc._July 28, 2026 0000730464 false 0000730464 2026-07-28 2026-07-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earl
2 min readBeard, Stephen W. (Chairman & CEO) sold 5,291 shares of Covista Inc. (CVSA) at $132.75 ($0.70M total) on 2026-07-13 under a Rule 10b5-1 trading plan.
1 min readPhelan Robert J. (Chief Financial Officer) sold 5,314 shares of Covista Inc. (CVSA) at an average of $135.40 ($135.39–$135.41, $0.72M total) across 2 trades over 2026-07-07 to 2026-07-08 under a Rule 10b5-1 trading plan.
2 min read
